NCT02660645 Blue Light Cystoscopy With Cysview® Registry
| NCT ID | NCT02660645 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Photocure |
| Condition | Bladder Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,400 participants |
| Start Date | 2014-04 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,400 participants in total. It began in 2014-04 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Eligibility Criteria
Inclusion Criteria: * Adult \>18 years old * Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy Exclusion Criteria: * Porphyria * Gross hematuria * Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives
Contact & Investigator
Siamak Daneshmand, MD
PRINCIPAL INVESTIGATOR
University of Southern California
Frequently Asked Questions
Who can join the NCT02660645 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bladder Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02660645 currently recruiting?
Yes, NCT02660645 is actively recruiting participants. Contact the research team at chad.mckee@photocure.com for enrollment information.
Where is the NCT02660645 trial being conducted?
This trial is being conducted at Birmingham, United States, Phoenix, United States, Los Angeles, United States, Los Angeles, United States and 11 additional locations.
Who is sponsoring the NCT02660645 clinical trial?
NCT02660645 is sponsored by Photocure. The principal investigator is Siamak Daneshmand, MD at University of Southern California. The trial plans to enroll 4,400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.